Opportunities and challenges for innovative and equitable healthcare

David J. Ecker; Clarice D. Aiello; Joseph R. Arron; C. Frank Bennett; Amy Bernard; Xandra O. Breakefield; Timothy J. Broderick; Shawneequa L. Callier; Barry Canton; Janice S. Chen; C. Simone Fishburn; Banning Garrett; Sidney M. Hecht; Tobias Janowitz; Melinda Kliegman; Adrian Krainer; Chrystal U. Louis; Christopher Lowe; Alfica Sehgal; Yesim Tozan; Kevin J. Tracey; Fyodor Urnov; Daniel Wattendorf; Thomas W. Williams; Xuanhe Zhao; Michael R. Hayden

doi:10.1038/d41573-024-00032-4

Opportunities and challenges for innovative and equitable healthcare

David J. Ecker, Clarice D. Aiello, Joseph R. Arron, C. Frank Bennett, Amy Bernard, Xandra O. Breakefield, Timothy J. Broderick, Shawneequa L. Callier, Barry Canton, Janice S. Chen, C. Simone Fishburn, Banning Garrett, Sidney M. Hecht, Tobias Janowitz, Melinda Kliegman, Adrian Krainer, Chrystal U. Louis, Christopher Lowe, Alfica Sehgal, Yesim TozanKevin J. Tracey, Fyodor Urnov, Daniel Wattendorf, Thomas W. Williams, Xuanhe Zhao, Michael R. Hayden

Global Public Health

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

An unprecedented number of potentially disruptive therapeutic technologies are under development. Forward-looking policies, incentives and infrastructure are needed to harness these advances to provide effective and globally equitable healthcare.

Original language	English (US)
Pages (from-to)	321-322
Number of pages	2
Journal	Nature Reviews Drug Discovery
Volume	23
Issue number	5
DOIs	https://doi.org/10.1038/d41573-024-00032-4
State	Published - May 2024

ASJC Scopus subject areas

Pharmacology
Drug Discovery

Access to Document

10.1038/d41573-024-00032-4

Cite this

Ecker, D. J., Aiello, C. D., Arron, J. R., Bennett, C. F., Bernard, A., Breakefield, X. O., Broderick, T. J., Callier, S. L., Canton, B., Chen, J. S., Fishburn, C. S., Garrett, B., Hecht, S. M., Janowitz, T., Kliegman, M., Krainer, A., Louis, C. U., Lowe, C., Sehgal, A., ... Hayden, M. R. (2024). Opportunities and challenges for innovative and equitable healthcare. Nature Reviews Drug Discovery, 23(5), 321-322. https://doi.org/10.1038/d41573-024-00032-4

Ecker, DJ, Aiello, CD, Arron, JR, Bennett, CF, Bernard, A, Breakefield, XO, Broderick, TJ, Callier, SL, Canton, B, Chen, JS, Fishburn, CS, Garrett, B, Hecht, SM, Janowitz, T, Kliegman, M, Krainer, A, Louis, CU, Lowe, C, Sehgal, A, Tozan, Y, Tracey, KJ, Urnov, F, Wattendorf, D, Williams, TW, Zhao, X & Hayden, MR 2024, 'Opportunities and challenges for innovative and equitable healthcare', Nature Reviews Drug Discovery, vol. 23, no. 5, pp. 321-322. https://doi.org/10.1038/d41573-024-00032-4

@article{4a6499c5673b464cb3865ee1a293256a,

title = "Opportunities and challenges for innovative and equitable healthcare",

abstract = "An unprecedented number of potentially disruptive therapeutic technologies are under development. Forward-looking policies, incentives and infrastructure are needed to harness these advances to provide effective and globally equitable healthcare.",

author = "Ecker, {David J.} and Aiello, {Clarice D.} and Arron, {Joseph R.} and Bennett, {C. Frank} and Amy Bernard and Breakefield, {Xandra O.} and Broderick, {Timothy J.} and Callier, {Shawneequa L.} and Barry Canton and Chen, {Janice S.} and Fishburn, {C. Simone} and Banning Garrett and Hecht, {Sidney M.} and Tobias Janowitz and Melinda Kliegman and Adrian Krainer and Louis, {Chrystal U.} and Christopher Lowe and Alfica Sehgal and Yesim Tozan and Tracey, {Kevin J.} and Fyodor Urnov and Daniel Wattendorf and Williams, {Thomas W.} and Xuanhe Zhao and Hayden, {Michael R.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Limited 2024.",

year = "2024",

month = may,

doi = "10.1038/d41573-024-00032-4",

language = "English (US)",

volume = "23",

pages = "321--322",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Research",

number = "5",

}

TY - JOUR

T1 - Opportunities and challenges for innovative and equitable healthcare

AU - Ecker, David J.

AU - Aiello, Clarice D.

AU - Arron, Joseph R.

AU - Bennett, C. Frank

AU - Bernard, Amy

AU - Breakefield, Xandra O.

AU - Broderick, Timothy J.

AU - Callier, Shawneequa L.

AU - Canton, Barry

AU - Chen, Janice S.

AU - Fishburn, C. Simone

AU - Garrett, Banning

AU - Hecht, Sidney M.

AU - Janowitz, Tobias

AU - Kliegman, Melinda

AU - Krainer, Adrian

AU - Louis, Chrystal U.

AU - Lowe, Christopher

AU - Sehgal, Alfica

AU - Tozan, Yesim

AU - Tracey, Kevin J.

AU - Urnov, Fyodor

AU - Wattendorf, Daniel

AU - Williams, Thomas W.

AU - Zhao, Xuanhe

AU - Hayden, Michael R.

PY - 2024/5

Y1 - 2024/5

N2 - An unprecedented number of potentially disruptive therapeutic technologies are under development. Forward-looking policies, incentives and infrastructure are needed to harness these advances to provide effective and globally equitable healthcare.

AB - An unprecedented number of potentially disruptive therapeutic technologies are under development. Forward-looking policies, incentives and infrastructure are needed to harness these advances to provide effective and globally equitable healthcare.

UR - http://www.scopus.com/inward/record.url?scp=85186259913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85186259913&partnerID=8YFLogxK

U2 - 10.1038/d41573-024-00032-4

DO - 10.1038/d41573-024-00032-4

M3 - Comment/debate

C2 - 38409339

AN - SCOPUS:85186259913

SN - 1474-1776

VL - 23

SP - 321

EP - 322

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

IS - 5

ER -

Opportunities and challenges for innovative and equitable healthcare

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this